🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sabrina Arena

Candiolo Cancer Institute

ORCID: 0000-0002-1318-2494

Also affiliated with University of Turin

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial”.

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial

ESMO Open(2025)10.1016/j.esmoop.2025.105892
N/A
0DataRank · unranked
0 citations

Salvatore Siena, A. Sartore-Bianchi, Javier Ros, F. Ciardello, E. Martinelli +38 more

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0187
N/A
0DataRank · unranked
493 citations

Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato +24 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571
N/A
0DataRank · unranked
70 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0614
N/A
0DataRank · unranked
12 citations

Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra +19 more